Anson Cheuk Man Chau

Anson Cheuk Man Chau

Auto-generated profile, based on publicly available information

Anson Cheuk Man Chau

Medical Radiation Science, Allied Health and Human Performance Unit, University of South Australia, City East Campus, Bonython Jubilee Building, 1-26, Adelaide, SA 5001, Australia

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2013 in Clinical Oral Implants Research
Verified
Journal Article
Closed access
PDF file
AZAhmed Zekry
Ahmed Zekry
RWRen Wang
Ren Wang
ACAnson C. M. Chau
Anson C. M. Chau
NLNiklaus P. Lang
Niklaus P. Lang

1 April 2009 in Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology
Verified
Journal Article
Closed access
ACAnson C.M. Chau
Anson C.M. Chau
KFKarl Fung
Karl Fung

1 January 2020 in NeuroImage: Clinical
Verified
Journal Article
Open access
ACAnson C.M. Chau
Anson C.M. Chau
ECEva Y.W. Cheung
Eva Y.W. Cheung
KCKoon Ho Chan
Koon Ho Chan
WCW.S. Chow
W.S. Chow
YSY.F. Shea
Y.F. Shea
Henry Ka-Fung MakHenry Ka-Fung Mak
Henry Ka-Fung Mak
The link between non-demented type 2 diabetes mellitus (T2DM) and different types of cognitive impairment is controversial. By controlling for co-morbidities such as cerebral macrovascular and microvascular changes, cerebral atrophy, amyloid burden, hypertension or hyperlipidemia, the current study investigated the cerebral blood flow of T2DM individuals as compared to cognitively impaired subjects recruited from a memory clinic. 15 healthy control (71.8 ± 6.1 years), 18 T2DM (62.5 ± 3.7 years), as well as 8 Subjective Cognitive Decline (69.5 ± 7.5 years), 12 Vascular Dementia (79.3 ± 4.2 years) and 17 Alzheimer's Disease (75.1 ± 8.2 years) underwent multi-parametric MRI brain scanning. Subjects with T2DM and from the memory clinic also had 18-F Flutametamol PET-CT scanning to look for any amyloid burden. Pseudocontinuous Arterial Spin Labeling (PCASL), MR Angiography Head, 3D FLAIR and 3D T1-weighted sequences were used to quantify cerebral blood flow, cerebrovascular changes, white matter hyperintensities and brain atrophy respectively. Vascular risk factors were retrieved from the medical records. The 37 subjects from memory clinic were classified into subjective cognitive decline (SCD), vascular dementia (VD) and Alzheimer's disease (AD) subgroups by a multi-disciplinary panel consisting of a neuroradiologist, and 2 geriatricians. Absolute cortical CBF in our cohort of T2DM, SCD, VD and AD was significantly decreased (p < 0.01) as compared to healthy controls (HC) in both whole brain and eight paired brain regions, after age, normalized grey matter volume and gender adjustment and Bonferroni correction. Subgroup analysis between T2DM, SCD, VD, and AD revealed that CBF of T2DM was not significantly different from AD, VD or SCD. By controlling for co-morbidities, impaired cortical CBF in T2DM was not related to microangiopathy or amyloid deposition, but to the interaction of triple risk factors (such as diabetes mellitus, hypertension, and hyperlipidemia). There was statistically significant negative correlation (p ≤ 0.05) between adjusted CBF and HbA1c in all brain regions of T2DM and HC (with partial correlation ranging from -0.30 to -0.46). Taken together, altered cerebral blood flow in T2DM might be related to disruption of cerebrovascular autoregulation related to vascular risk factors, and such oligemia occurred before clinical manifestation due to altered glycemic control.

16 August 2004 in Ophthalmic and Physiological Optics
Verified
Journal Article
Closed access
PDF file
ACAnson Chau
Anson Chau
KFKarl Fung
Karl Fung
LYLawrance Yip
Lawrance Yip
MYMaurice Yap
Maurice Yap

22 December 2003 in Ophthalmic and Physiological Optics
Verified
Journal Article
Closed access
PDF file
ACAnson Chau
Anson Chau
KFKarl Fung
Karl Fung
KPKaren Pak
Karen Pak
MYMaurice Yap
Maurice Yap